MANDY GORDON: Open Payments
NPI 1497195598 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,294 in 150 payments from 33 companies in 2025. Trend: 2023 $2,975 · 2024 $2,937 · 2025 $3,294
Food & beverage: $3,194Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $547 |
| Daiichi Sankyo Inc. | 12 | $459 |
| Novartis Pharmaceuticals Corporation | 18 | $248 |
| Merck Sharp & Dohme LLC | 12 | $239 |
| GlaxoSmithKline, LLC. | 7 | $201 |
| Incyte Corporation | 5 | $191 |
| AstraZeneca Pharmaceuticals LP | 6 | $170 |
| PFIZER INC. | 12 | $164 |
| ABBVIE INC. | 9 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $110 |
Products named: DATROWAY, KEYTRUDA, Monjuvi, JEMPERLI, ERLEADA, Enhertu, RYBREVANT, DARZALEX.
Industry payments across AR — which companies pay providers there.
